Company profile
BetterLife Pharma Inc.
OTC: BETRF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCCIK 0001464165Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 48
v0.1 · 5/100 weight · pillars only
↑ listing tenure, return on assets · ↓ filing timeliness, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$121.2k
Employees
7
as of 2026-08-21
Market cap
$39.8M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$121.2k-$121.2k2018
Operating income-$1.0M-$1.0M2018
Total assets$383.8k$383.8k2018
Liabilities$429.2k$429.2k2018
Equity-$45.4k-$45.4k2018
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BetterLife Pharma Inc.’s financial profile?
BetterLife Pharma Inc. earned -$121.2k in FY2018 net income.
Peers · Healthcare
Context Therapeutics Inc.——Cell Source, Inc.——Rocket Doctor AI Inc.——BriaCell Therapeutics Corp.——Obsidian Therapeutics Inc.——MIRA Pharmaceuticals, Inc.——Key facts
CEOAhmad Doroudian
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: BETRF
Employees7
IPO date2010-09-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.